The Universal Selection Source: Cosmetics Ingredients

Industry News

Insilico Collaborates with Harvard & Oxford to Develop Biomarkers for Aging from Mice

Published on 2017-09-07. Author : SpecialChem

Insilico Medicine, Inc has announced its participation in the initiative to develop novel photographic biomarkers of aging in mice.

Insilico Collaborates to Develop Biomarkers for Aging
Insilico Collaborates with Harvard & Oxford to Develop
Biomarkers for Aging from Mice

Studying Aging to Develop Biomarkers

The scientists from Insilico Medicine will collaborate with scientists from Harvard, Oxford, Youth Laboratories, the Biogerontology Research Foundation, and other institutions to enable scientists worldwide to derive more information from rodent studies, develop novel biomarkers of aging and various diseases in mice, develop tools for cross-species analysis, and provide correlations between health and appearance.

The project campaign has been launched recently at research crowdfunding platform The project was conceived by Vadim Gladyshev, Professor of Medicine at Brigham and Women's Hospital, Harvard Medical School, and Alex Zhavoronkov, CEO of Insilico Medicine. It is managed by the Biogerontology Research Foundation, a registered UK charity.

Vadim Gladyshev said:

"There are many experiments conducted around the world that examine lifespan in mice. The artificially intelligent MouseAge system will help determine which interventions make mice look younger. The plan is to develop an accurate predictor of mouse biological age based on images of mice and then apply transfer learning techniques to other datasets and data types."

Biomarkers to Focus on Human Skin

The project is expected to foster collaboration among biogerontologists and artificial intelligence researchers who are interested in contributing to extending healthy longevity. Insilico Medicine is using the field of "omics" to develop a broad range of deep-learned biomarkers of aging and age-related diseases, and Youth Laboratories is developing highly accurate biomarkers of aging and health status using pictures and video that primarily focus on human skin.

PhD, CEO of Insilico Medicine, Alex Zhavoronkov said:

"Aging research is the most altruistic cause that can generate billions of quality-adjusted life years over time and save the global economy. We are very happy to contribute to and support the MouseAge project. Our Young.AI system for tracking multiple biomarkers during human aging is currently in the alpha stage and is launching in the fall. However, the biological relevance of many of the biomarkers and interventions is yet to be established, and the MouseAge project contributes to the body of fundamental science required to bridge AI and longevity research. Please support the MouseAge project on to contribute to this grand effort."

PS: If you liked this News, you might enjoy our Cosmetics Industry Newsletter. All the Industry News delivered once a week right to your inbox. Sign up here!

Source: Insilico Medicine
Be the first to comment on "Insilico Collaborates with Harvard & Oxford to Develop Biomarkers for Aging from Mice"

Leave a comment

Your email address and name will not be published submitting a comment or rating implies your acceptance to SpecialChem Terms & Conditions
Back to Top